ATRC · Forms 3, 4, 5
Insider trades at AtriCure, Inc.
1 insider sold $271K of AtriCure, Inc. stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for AtriCure, Inc. (ATRC) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Salvatore Privitera | Chief Technical Officer | Sell | 4,519 | $60.00 | $271K | Form 4 | |
| Regina E Groves | Director | Sell | 5,313 | $54.22 | $288K | Form 4 | |
| Salvatore Privitera | Chief Technical Officer | Sell | 3,657 | $55.00 | $201K | Form 4 | |
| Salvatore Privitera | Chief Technical Officer | Sell | 7,763 | $52.50 | $408K | Form 4 | |
| Karl S. Dahlquist | Chief Legal Officer | Sell | 9,370 | $48.89 | $458K | Form 4 | |
| Karen Prange | Director | Sell | 3,564 | $38.80 | $138K | Form 4 | |
| Maggie Yuen | Director | Sell | 3,500 | $38.42 | $134K | Form 4 | |
| Michael H Carrel | President, CEO, & Director | Gift | 700 | Form 4 | |||
| Michael H Carrel | President, CEO, & Director | Gift | 4,000 | Form 4 | |||
| Justin J Noznesky | Chief Mktg & Strategy Officer | Sell | 6,182 | $38.80 | $240K | Form 4 | |
| Vinayak Doraiswamy | Chief Scientific Officer | Sell | 6,000 | $38.88 | $233K | Form 4 | |
| Sven Wehrwein | Director | Option exercise | 25,000 | $19.95 | $499K | Form 4 | |
| Sven Wehrwein | Director | Sell | 25,000 | $37.84 | $946K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.